Treatment Efficacy for Patients With Chronic Hepatitis C and Preexisting Hepatocellular Carcinoma by Directly Acting Antivirals

Hepatoma Research
doi 10.20517/2394-5079.2019.40
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OAE Publishing Inc.

Related search

The Interplay Between Direct-Acting Antivirals and Hepatocellular Carcinoma in Chronic Hepatitis C

Hepatoma Research
2020English

Unexpected Viral Relapses in Hepatitis C Virus-Infected Patients Diagnosed With Hepatocellular Carcinoma During Treatment With Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Treatment of Hepatitis C With Direct-Acting Antivirals in Patients With Hepatocellular Carcinoma Before Liver Transplantation: Still an Open Issue

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

High Efficacy of Generic and Brand Direct Acting Antivirals in Treatment of Chronic Hepatitis C.

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2018English

Treatment Efficacy of All-Oral Combinations of Direct-Acting Antivirals in Chronic Hepatitis C Patients With NS5A-P32 Deletion

Acta Hepatologica Japonica
Hepatology
2017English

Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy With Direct-Acting Antivirals

Journal of Hepatology
Hepatology
2017English

Serial Changes of Renal Function After Directly Acting Antivirals Treatment for Chronic Hepatitis C: A 1-Year Follow-Up Study After Treatment

PLoS ONE
Multidisciplinary
2020English

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy